Patents by Inventor Kouacou Adiey

Kouacou Adiey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
    Patent number: 10035761
    Abstract: The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present invention also provides methods of using phenylcycloalkylmethylamine derivatives and compositions of phenylcycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: July 31, 2018
    Assignee: Revivia Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Kouacou Adiey, Seema Rani Bhat
  • Arylpiperazine derivatives and methods of utilizing same
    Patent number: 9975862
    Abstract: The present invention provides arylpiperazine derivatives having Formula I as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: May 22, 2018
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • COMPOSITIONS, SYNTHESIS, AND METHODS OF USING PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES
    Publication number: 20180127362
    Abstract: The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present invention also provides methods of using phenylcycloalkylmethylamine derivatives and compositions of phenylcycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.
    Type: Application
    Filed: June 30, 2017
    Publication date: May 10, 2018
    Inventors: Laxminarayan BHAT, Kouacou ADIEY, Seema Rani BHAT
  • ARYLPIPERAZINE DERIVATIVES AND METHODS OF UTILIZING SAME
    Publication number: 20170327477
    Abstract: The present invention provides arylpiperazine derivatives having Formula I as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,
    Type: Application
    Filed: March 27, 2017
    Publication date: November 16, 2017
    Inventors: Laxminarayan BHAT, Prabhu Prasad MOHAPATRA, Kouacou ADIEY
  • Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
    Patent number: 9695116
    Abstract: The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present invention also provides methods of using phenylcycloalkylmethylamine derivatives and compositions of phenylcycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: July 4, 2017
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Kouacou Adiey, Seema Rani Bhat
  • Arylpiperazine derivatives and methods of utilizing same
    Patent number: 9604944
    Abstract: The present invention provides arylpiperazine derivatives having Formula 1a as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: March 28, 2017
    Assignee: REVIVA PHARMACEUTICALS, INC.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • ARYLPIPERAZINE DERIVATIVES AND METHODS OF UTILIZING SAME
    Publication number: 20160229821
    Abstract: The present invention provides arylpiperazine derivatives having Formula I as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,
    Type: Application
    Filed: February 8, 2016
    Publication date: August 11, 2016
    Inventors: Laxminarayan BHAT, Prabhu Prasad MOHAPATRA, Kouacou ADIEY
  • COMPOSITIONS, SYNTHESIS, AND METHODS OF USING PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES
    Publication number: 20160115121
    Abstract: The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present invention also provides methods of using phenylcycloalkylmethylamine derivatives and compositions of phenylcycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 28, 2016
    Inventors: Laxminarayan BHAT, Kouacou ADIEY, Seema Rani BHAT
  • Arylpiperazine derivatives and methods of utilizing same
    Patent number: 9255076
    Abstract: The present invention provides arylpiperazine derivatives having Formula I as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: February 9, 2016
    Assignee: REVIVA PHARMACEUTICALS, INC.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
    Patent number: 9238625
    Abstract: The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present invention also provides methods of using phenylcycloalkylmethylamine derivatives and compositions of phenylcycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.
    Type: Grant
    Filed: December 31, 2012
    Date of Patent: January 19, 2016
    Assignee: REVIVA PHARMACEUTICALS, INC.
    Inventors: Laxminarayan Bhat, Kouacou Adiey, Seema Rani Bhat
  • Methods of using cycloalkylmethylamine derivatives
    Patent number: 9096515
    Abstract: The present invention provides novel cycloalkylmethylamine derivatives, and methods of preparing cycloalkylmethylamine derivatives. The present invention also provides methods of using cycloalkylmethylamine derivatives and compositions of cycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.
    Type: Grant
    Filed: September 26, 2013
    Date of Patent: August 4, 2015
    Assignee: REVIVA PHARMACEUTICALS, INC.
    Inventors: Laxminarayan Bhat, Kouacou Adiey
  • ARYLPIPERAZINE DERIVATIVES AND METHODS OF UTILIZING SAME
    Publication number: 20150166493
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Inventors: Laxminarayan BHAT, Prabhu Prasad MOHAPATRA, Kouacou ADIEY
  • Arylpiperazine derivatives and methods of utilizing same
    Patent number: 8980883
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: March 17, 2015
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • ARYLPIPERAZINE DERIVATIVES AND METHODS OF UTILIZING SAME
    Publication number: 20150005298
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Application
    Filed: September 17, 2014
    Publication date: January 1, 2015
    Inventors: Laxminarayan BHAT, Prabhu Prasad MOHAPATRA, Kouacou ADIEY
  • Methods of utilizing arylpiperazine derivatives
    Patent number: 8859552
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Grant
    Filed: June 10, 2013
    Date of Patent: October 14, 2014
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • METHODS OF UTILIZING ARYLPIPERAZINE DERIVATIVES
    Publication number: 20140155392
    Abstract: The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.
    Type: Application
    Filed: June 10, 2013
    Publication date: June 5, 2014
    Applicant: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey
  • METHODS OF USING CYCLOALKYLMETHYLAMINE DERIVATIVES
    Publication number: 20140024709
    Abstract: The present invention provides novel cycloalkylmethylamine derivatives, and methods of preparing cycloalkylmethylamine derivatives. The present invention also provides methods of using cycloalkylmethylamine derivatives and compositions of cycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.
    Type: Application
    Filed: September 26, 2013
    Publication date: January 23, 2014
    Applicant: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan BHAT, Kouacou ADIEY
  • Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
    Patent number: 8604244
    Abstract: The present invention provides novel cycloalkylmethylamine derivatives, and methods of preparing cycloalkylmethylamine derivatives. The present invention also provides methods of using cycloalkylmethylamine derivatives and compositions of cycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications.
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: December 10, 2013
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Kouacou Adiey
  • Compositions, synthesis, and methods of utilizing quinazolinedione derivatives
    Patent number: 8575185
    Abstract: The present invention provides quinazolinedione derivatives of Formulae Ia and Ib, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, depression and dementia.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: November 5, 2013
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Sureshbabu Dadiboyena, Kouacou Adiey
  • Methods of utilizing arylpiperazine derivatives
    Patent number: 8461154
    Abstract: The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.
    Type: Grant
    Filed: May 7, 2012
    Date of Patent: June 11, 2013
    Assignee: Reviva Pharmaceuticals, Inc.
    Inventors: Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey